Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains a mixture of soy isoflavones (daidzein and genistein) and palmitoylethanolamide (PEA). Daidzein and genistein are phytoestrogens with potential antioxidant and anti-inflammatory properties. Palmitoylethanolamide is an endogenous fatty acid amide with proposed analgesic and anti-inflammatory effects.
## Primary Indications
This combination is typically used as a dietary supplement and is not approved by the FDA for any specific medical indication. Its use is often explored for conditions related to inflammation, pain, and potentially menopausal symptoms.
## Adult Dosing
Dosing is highly variable as this is a supplement. Common formulations range from:
* **Daidzein:** 20-50 mg daily
* **Genistein:** 20-50 mg daily
* **Palmitoylethanolamide (PEA):** 300-1200 mg daily, often divided into multiple doses.
Specific product recommendations should be followed.
## Pediatric Dosing
There is no established pediatric dosing for this combination product. Use in children is not recommended without specific clinical guidance and evidence.
## Dose Adjustments
No specific dose adjustments are established for renal or hepatic impairment due to its nature as a dietary supplement.
## Contraindications
* Hypersensitivity to any component of the formulation.
* Pregnancy and breastfeeding (due to potential hormonal effects of isoflavones).
* Individuals with hormone-sensitive cancers should use with caution and consult their oncologist.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal discomfort.
* **Hormonal:** Potential for menstrual irregularities in premenopausal women, breast tenderness.
* **Allergic Reactions:** Rash, itching.
* **PEA-specific:** Generally well-tolerated, but gastrointestinal upset can occur.
## Key Drug Interactions
* **Hormone Therapies:** Potential for additive effects or interference with hormone replacement therapy or hormonal contraceptives.
* **Tamoxifen:** Phytoestrogens may theoretically interact with tamoxifen due to estrogenic activity; clinical significance is uncertain.
* **Thyroid Medications:** Isoflavones may interfere with thyroid function; monitor thyroid function if used concurrently.
## Monitoring
* Monitor for adverse effects, particularly gastrointestinal upset and signs of hormonal changes.
* Consider monitoring for changes in inflammatory markers or pain levels if used for these purposes.
* If used by patients with thyroid conditions, consider periodic thyroid function tests.
## Clinical Pearls
* This is a dietary supplement, not a pharmaceutical agent, and lacks rigorous clinical trial data to support specific dosing or efficacy for medical conditions.
* The absorption and metabolism of daidzein and genistein can be influenced by gut microbiota.
* PEA is an endogenous compound, and supplementation aims to enhance its natural anti-inflammatory pathways.
***
*Please verify the most current prescribing information and consult with a healthcare professional for specific patient care decisions.*
